USPTO serial 88103626
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | (Based on 44(e)) Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; Serums; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing | SECTION 8 - CANCELLED | — |
| 042 | (Based on 44(e)) Scientific and technological services, namely, research and design in the field of medicine and health; Design and development of software and data bases; Medical research; Research relating to biology and biotechnology; Pharmaceutical research services; Clinical research in the field of cancer and autoimmune diseases; Research and development services in the field of immunology; research and development in the field of microorganisms, cells and antibodies; Research and development of vaccines and medicines; biological analysis; Biological laboratory services; Advice on research and development in the field of therapeutics; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies | SECTION 8 - CANCELLED | — |
| 044 | (Based on 44(e)) Provision of medical services; Advice relating to immunology; Therapy services in the nature of therapeutic health care services | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 20, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 10, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 10, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 7, 2019 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Aug 7, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 18, 2019 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jul 18, 2019 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Apr 2, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 5, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 5, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 16, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 28, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 27, 2018 | ALIE | ASSIGNED TO LIE | — |
| Dec 20, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 15, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 11, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 7, 2018 | NWAP | NEW APPLICATION ENTERED | — |